Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association)

Stroke. 2002 Jul;33(7):1934-42. doi: 10.1161/01.str.0000028456.18614.93.

Authors

B M Coull¹, L S Williams, L B Goldstein, J F Meschia, D Heitzman, S Chaturvedi, K C Johnston, S Starkman, L B Morgenstern, J L Wilterdink, S R Levine, J L Saver; Joint Stroke Guideline Development Committee of the American Academy of Neurology; American Stroke Association

Affiliation

¹ Department of Neurology, Arizona Health Science Center, Tucson, Ariz, USA.

PMID: 12105379
DOI: 10.1161/01.str.0000028456.18614.93

No abstract available

Publication types

Guideline
Practice Guideline
Review

MeSH terms

Anticoagulants / adverse effects
Anticoagulants / therapeutic use*
Brain Ischemia / complications
Brain Ischemia / drug therapy*
Cardiovascular Diseases / prevention & control
Clinical Trials as Topic / statistics & numerical data
Humans
Multicenter Studies as Topic / statistics & numerical data
Platelet Aggregation Inhibitors / adverse effects
Platelet Aggregation Inhibitors / therapeutic use*
Pulmonary Embolism / prevention & control
Risk Assessment
Secondary Prevention
Stroke / complications
Stroke / drug therapy*
Time Factors
Treatment Outcome
Venous Thrombosis / prevention & control

Substances

Anticoagulants
Platelet Aggregation Inhibitors